United Network for Organ Sharing regional variations in appeal denial rates with non‐standard Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exceptions: support for a national review board

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|6|513-522

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.6, 2015-06, pp. : 513-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of model for end‐stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 4, 2015-04 ,pp. : 554-560

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myelodysplasia-Like Syndrome and End-Stage Liver Disease

By  

Acta Haematologica, Vol. 105, Iss. 2, 2001-06 ,pp. : 100-102

Karger

Access to resources Recommend Favorite

Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1643-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival outcomes in liver transplant recipients with Model for End‐stage Liver Disease scores of 40 or higher: a decade‐long experience

By  

HPB, Vol. 17, Iss. 12, 2015-12 ,pp. : 1074-1084

John Wiley & Sons Inc

Access to resources Recommend Favorite

Keeping high model for end‐stage liver disease score liver transplantation candidates alive

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 11, 2015-11 ,pp. : 1428-1437

John Wiley & Sons Inc

Access to resources Recommend Favorite